Mike Mensinger, Chief Product Officer at Beta Bionics, Inc. (BBNX), sold 1,115 shares at $18.69 ($20K) on 2025-06-02, disclosed to the SEC on 2025-06-04.
Open-market sale of $20k BBNX by Chief Product Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.03 | 306 | $5K | 26.1% |
| 2 | $18.15 | 708 | $13K | 64.4% |
| 3 | $18.69 | 101 | $2K | 9.5% |
| Total | $17.89 avg | 1,115 | $20K | 100% |
| Filing → |
| BBNX | SELL | 2026-06-03 | $55K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $13K | — | Filing → |
| BBNX | SELL | 2026-01-07 | $66K | — | Filing → |